Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution
Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
11/2003
11/27/2003CA2485847A1 Glucan-based vaccines
11/27/2003CA2481799A1 Recombinant poxvirus expressing homologous genes inserted into the poxviral genome
11/26/2003EP1365034A2 Methods and compositions for the prediction, diagnosis, prognosis, prevention and treatment of malignant neoplasia
11/26/2003EP1365032A1 Marker molecules associated with lung tumors
11/26/2003EP1364944A1 Frangible Compounds for Pathogen Inactivation
11/26/2003EP1364642A1 Composition for delivery of dithranol
11/26/2003EP1364586A1 Probiotics and oral tolerance
11/26/2003EP1364038A2 Adenovirus particles with mutagenized fiber proteins
11/26/2003EP1364019A2 Methods and compositions relating to muscle specific sarcomeric calcineurin-binding proteins (calsarcins)
11/26/2003EP1364011A2 Modified thrombopoietin with reduced immunogenicity
11/26/2003EP1363994A2 Thymic epithelial progenitor cells and uses thereof
11/26/2003EP1363948A1 Polypeptide of a p53 protein-specific murine alpha/beta t-cell receptor, nucleic acids coding therefor and use thereof
11/26/2003EP1363943A2 Interferon regulatory factor-1/human estrogen receptor fusion protein and its use for treating carcinomas
11/26/2003EP1363942A2 Polypeptide from a hdm2 protein specific murine alpha/beta t-cell receptors, nucleic acids coding for the above and use thereof
11/26/2003EP1363938A2 Molecular vaccine linking an endoplasmic reticulum chaperone polypeptide to an antigen
11/26/2003EP1363703A2 Disease prevention by reactivation of the thymus
11/26/2003EP1363674A2 Agents and methods for treating pain
11/26/2003EP1363671A2 Water-soluble compositions of bioactive lipophilic compounds
11/26/2003EP1363663A2 Nucleic acid mucosal immunization
11/26/2003EP1363650A2 AQUATIC ANIMAL TREATMENT METHOD AND COMPOSITION CONTAINING i PIMENTA /i EXTRACT
11/26/2003EP1363646A1 Preparation of cartilage extracts using organic solvents
11/26/2003EP1363616A1 Carboxylic acid such as citric acid for disinfecting or enhancing the production of blood products such as plasma, cryoprecipitate or/and platelet
11/26/2003EP1363557A1 Bioartificial device for storing, cultivating and/or reproducing cells
11/26/2003EP1363528A2 Methods for diagnosing and treating heart disease
11/26/2003EP0988043B1 Method and product using sturgeon notochord for alleviating the symptoms of arthritis
11/26/2003CN1458974A Stimulation of cartilage growth with agonists of non-protecolytically activated thrombin receptor
11/26/2003CN1458273A Separating preparing and use of human fetal dorsal root ganglionic stem cell
11/26/2003CN1457881A Gelatin-blood plasma and its preparing method
11/26/2003CN1457866A Quick-acting Chinese patent medicine for treating sleeplessness
11/26/2003CN1457848A Black-bone chicken white phoenix preparation medicine and its preparing method
11/26/2003CN1457845A Medicinal wine for curing old injury recurrent pain
11/26/2003CN1457838A Chines medicinal composition for curing hepatitis B
11/26/2003CN1457824A Chinese medicinal pill for reinforcing kidney and strengthening yang, warming and recuperating Qi and blood, and improving crganism immunity
11/26/2003CN1457821A Medicine for curing aseptic necrosis of head of femur
11/26/2003CN1457819A Beautifying health composition
11/26/2003CN1457802A Snake powder and leech powder composition and preparing method
11/26/2003CN1457801A Medicinal composition for curing common cold
11/26/2003CN1457692A Local specific pearl (travel) food
11/26/2003CN1128634C Pure Chinese medicine preparation for curing hepatitis B
11/26/2003CN1128631C External-use medicinal plaster for curing bone disease
11/26/2003CN1128630C Functional tonifying health-care product produced by utilizing enzyme engineering and its producing method
11/26/2003CN1128628C Chinese medicine for treating alopecia areata
11/26/2003CN1128627C Plaster for treating rheumatism and its preparing method
11/26/2003CN1128626C Health-care medicinal wine for invigorating function of kidney and strengthening bone
11/26/2003CN1128624C Process for preparing powdered medicine to treat rhinitis and nasosinusitis
11/25/2003US6653382 Ethylene-unsaturated carboxylic acid copolymer; ionomers; resilience, melt processability
11/25/2003US6653291 Composition and method for production of transformed cells
11/25/2003US6653134 Obtaining a bone marrow sample from a human, isolating stromal cells, and administering to the central nervous system of the patient; treating a genetic disease, a tumor, trauma and stroke
11/25/2003US6653131 Method of treating systemic inflammatory response syndrome
11/25/2003US6653089 Generating flowing fluid against surface of cell; obtain cell, incubate with binding agent, monitor position of binding agent in cell
11/25/2003US6652887 Bone graft substitute composition
11/25/2003US6652879 Improving the palatability of fish oil medicinals; gelatin, gelatin softener, water and water soluble flavoring agent
11/25/2003US6652872 Support for the propagation of preferential tissues
11/25/2003US6652848 Dendritic cell hybrids
11/25/2003CA2194166C Multi-stage cascase boosting vaccine
11/25/2003CA2143830C Systems and methods for reducing leukocytes in cellular products
11/21/2003CA2428112A1 Methods and compositions for the prediction, diagnosis, prognosis, prevention and treatment of malignant neoplasia
11/20/2003WO2003096017A1 Methods and compositions for inducing an immune response
11/20/2003WO2003095656A1 Recombinant fowlpox virus
11/20/2003WO2003095634A1 Pax-5-deficient pro-b-cells, methods of producing them and the use of such cells in human therapy
11/20/2003WO2003095631A1 Method for establishing and expanding multipotent stem cells
11/20/2003WO2003095630A2 Bioartificial skin comprising genetically modified fibroblasts
11/20/2003WO2003095629A1 Production of neural progenitor cells
11/20/2003WO2003095613A2 Nucleic acids, polypeptides, and methods for modulating apoptosis
11/20/2003WO2003095606A2 A t cell subpopulation regulating gut immunity
11/20/2003WO2003095016A1 System and method for forming a non-ablative cardiac conduction block
11/20/2003WO2003094979A1 Method for preventing damage to or rejuvenating a cellular blood component using mitochondrial enhancer
11/20/2003WO2003094970A1 A fungus inhibiting biological compound
11/20/2003WO2003094941A1 Traditional chinese pharmaceutical formulation for treatment of paradentosis, process for preparation and use thereof
11/20/2003WO2003094939A1 Sensitization of neoplastic cells to radiation therapy with oncolytic viruses
11/20/2003WO2003094938A1 Method for reducing pain using oncolytic viruses
11/20/2003WO2003094937A1 A pharmaceutical composition for treatment of wounds containing blood plasma or serum
11/20/2003WO2003094936A1 Method for extended storage of blood and blood components
11/20/2003WO2003094855A1 System and method for treating cardiac arrhythmias with fibroblast cells
11/20/2003WO2003094837A2 Treatments with autologous fibroblast
11/20/2003WO2003094836A2 Methods and products for enhancing immune responses using imidazoquinoline compounds
11/20/2003WO2003073995A3 Dna vaccine against proliferating endothelial cells and methods of use thereof.
11/20/2003WO2003072133A3 Immunostimulatory agent comprising a biomass of methanotrophic bacterium
11/20/2003WO2003072016A3 Pharmaceutical compositions in particulate form
11/20/2003WO2003065971A9 Non-myeloablative tolerogenic treatment with tyrphostins
11/20/2003WO2003055915A3 Human netrin receptor and uses thereof
11/20/2003WO2003054012A3 Leptin proteins
11/20/2003WO2003049752A3 Gram positive bacteria preparations for the treatment of diseases comprising an immune dysregulation
11/20/2003WO2003039465A3 Treating canker sores with patches to speed healing and relieve pain
11/20/2003WO2003039458A3 TREATMENT OF HUMAN CANCER WITH ADENOVIRAL VECTOR EXPRESSING TNF-α
11/20/2003WO2003038048A3 Ex-vivo rescue of transplantable hematopoietic stem cells following myeloablative injury
11/20/2003WO2003023018A3 A method for isolating, culturing and differentiating intestinal stem cells for therapeutic use
11/20/2003WO2003018767A3 Trans-differentiation and re-differentiation of somatic cells and production of cells for cell therapies
11/20/2003WO2003006616A3 Pseudotyped adeno-associated viruses and uses thereof
11/20/2003WO2003000021A3 Pancam nucleic acids and polypeptides
11/20/2003WO2002100420A3 Pharmaceutical zeolite-based compositions containing zinc and erythromycin, to be used in the treatment of acne
11/20/2003WO2002095011A3 Inactivation of genes of the mep pathway
11/20/2003WO2002062395A3 A method and system for introducing a gene into a human stem cell
11/20/2003WO2002062362A3 Antiviral and antibacterial composition
11/20/2003WO2002034915A3 Preferred segments of neural thread protein and methods of using the same
11/20/2003US20030217374 Genetically engineered rodent for use in generating immunoglobulins; genetic vaccines; antitumor agents; gene therapy
11/20/2003US20030216812 Vascularization enhanced graft constructs
11/20/2003US20030216811 Vascularization enhanced graft constructs
11/20/2003US20030216559 Medical diagnosis using polypeptide; amplification, determination, calibration; monitoring immunotherapy
11/20/2003US20030216397 A compound having a fused ecteinascidin five ring system with a 1,4 bridge; anticarcinogenic agent
1 ... 878 879 880 881 882 883 884 885 886 887 888 889 890 891 892 893 894 895 896 897 898 ... 1259